nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—trigeminal ganglion—peripheral nervous system neoplasm	0.00676	0.108	CbGeAlD
Hydroxocobalamin—TCN1—parotid gland—peripheral nervous system neoplasm	0.00574	0.092	CbGeAlD
Hydroxocobalamin—MMAA—brainstem—peripheral nervous system neoplasm	0.00566	0.0906	CbGeAlD
Hydroxocobalamin—TCN2—trigeminal ganglion—peripheral nervous system neoplasm	0.00547	0.0876	CbGeAlD
Hydroxocobalamin—MUT—trigeminal ganglion—peripheral nervous system neoplasm	0.0043	0.0689	CbGeAlD
Hydroxocobalamin—MUT—parotid gland—peripheral nervous system neoplasm	0.00406	0.065	CbGeAlD
Hydroxocobalamin—MTRR—trigeminal ganglion—peripheral nervous system neoplasm	0.00386	0.0619	CbGeAlD
Hydroxocobalamin—MTRR—parotid gland—peripheral nervous system neoplasm	0.00364	0.0584	CbGeAlD
Hydroxocobalamin—AMN—cerebellum—peripheral nervous system neoplasm	0.0035	0.0561	CbGeAlD
Hydroxocobalamin—MTR—trigeminal ganglion—peripheral nervous system neoplasm	0.00337	0.054	CbGeAlD
Hydroxocobalamin—MTR—parotid gland—peripheral nervous system neoplasm	0.00318	0.0509	CbGeAlD
Hydroxocobalamin—MMAA—cerebellum—peripheral nervous system neoplasm	0.00279	0.0447	CbGeAlD
Hydroxocobalamin—MMAB—cerebellum—peripheral nervous system neoplasm	0.00262	0.0419	CbGeAlD
Hydroxocobalamin—CASP9—cerebellum—peripheral nervous system neoplasm	0.00244	0.0392	CbGeAlD
Hydroxocobalamin—MUT—cerebellum—peripheral nervous system neoplasm	0.00188	0.0301	CbGeAlD
Hydroxocobalamin—MTRR—cerebellum—peripheral nervous system neoplasm	0.00169	0.027	CbGeAlD
Hydroxocobalamin—MTR—cerebellum—peripheral nervous system neoplasm	0.00147	0.0236	CbGeAlD
Hydroxocobalamin—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000883	0.00153	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000882	0.00153	CcSEcCtD
Hydroxocobalamin—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000879	0.00152	CcSEcCtD
Hydroxocobalamin—Pain—Melphalan—peripheral nervous system neoplasm	0.000874	0.00151	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000873	0.00151	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000872	0.00151	CcSEcCtD
Hydroxocobalamin—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000867	0.0015	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00086	0.00149	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00148	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000853	0.00148	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000853	0.00148	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000851	0.00148	CcSEcCtD
Hydroxocobalamin—Agitation—Vincristine—peripheral nervous system neoplasm	0.000851	0.00148	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00085	0.00147	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000848	0.00147	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000846	0.00147	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000845	0.00146	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00084	0.00146	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00084	0.00146	CcSEcCtD
Hydroxocobalamin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000829	0.00144	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000825	0.00143	CcSEcCtD
Hydroxocobalamin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000822	0.00143	CcSEcCtD
Hydroxocobalamin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000822	0.00143	CcSEcCtD
Hydroxocobalamin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000819	0.00142	CcSEcCtD
Hydroxocobalamin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.00142	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000818	0.00142	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000818	0.00142	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000813	0.00141	CcSEcCtD
Hydroxocobalamin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000812	0.00141	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000811	0.00141	CcSEcCtD
Hydroxocobalamin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000808	0.0014	CcSEcCtD
Hydroxocobalamin—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000805	0.0014	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.0008	0.00139	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00137	CcSEcCtD
Hydroxocobalamin—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00136	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00136	CcSEcCtD
Hydroxocobalamin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000782	0.00136	CcSEcCtD
Hydroxocobalamin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.00135	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000778	0.00135	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000777	0.00135	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000777	0.00135	CcSEcCtD
Hydroxocobalamin—Chills—Etoposide—peripheral nervous system neoplasm	0.000773	0.00134	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00077	0.00134	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000769	0.00133	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000769	0.00133	CcSEcCtD
Hydroxocobalamin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000766	0.00133	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00132	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00132	CcSEcCtD
Hydroxocobalamin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000762	0.00132	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00076	0.00132	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000756	0.00131	CcSEcCtD
Hydroxocobalamin—Oedema—Vincristine—peripheral nervous system neoplasm	0.000756	0.00131	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000753	0.00131	CcSEcCtD
Hydroxocobalamin—Infection—Vincristine—peripheral nervous system neoplasm	0.000751	0.0013	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.0013	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000747	0.00129	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000741	0.00129	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.00074	0.00128	CcSEcCtD
Hydroxocobalamin—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000739	0.00128	CcSEcCtD
Hydroxocobalamin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000738	0.00128	CcSEcCtD
Hydroxocobalamin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000732	0.00127	CcSEcCtD
Hydroxocobalamin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000732	0.00127	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000731	0.00127	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000723	0.00125	CcSEcCtD
Hydroxocobalamin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000723	0.00125	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.00125	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000714	0.00124	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.00124	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000708	0.00123	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000708	0.00123	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000701	0.00122	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000699	0.00121	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000699	0.00121	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000697	0.00121	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000696	0.00121	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000692	0.0012	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.0012	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00069	0.0012	CcSEcCtD
Hydroxocobalamin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00069	0.0012	CcSEcCtD
Hydroxocobalamin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000689	0.00119	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.00119	CcSEcCtD
Hydroxocobalamin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000684	0.00119	CcSEcCtD
Hydroxocobalamin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000684	0.00119	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000677	0.00117	CcSEcCtD
Hydroxocobalamin—Malaise—Etoposide—peripheral nervous system neoplasm	0.000677	0.00117	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000676	0.00117	CcSEcCtD
Hydroxocobalamin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00116	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000669	0.00116	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00116	CcSEcCtD
Hydroxocobalamin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00116	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00115	CcSEcCtD
Hydroxocobalamin—Infection—Cisplatin—peripheral nervous system neoplasm	0.000664	0.00115	CcSEcCtD
Hydroxocobalamin—Rash—Topotecan—peripheral nervous system neoplasm	0.000658	0.00114	CcSEcCtD
Hydroxocobalamin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000657	0.00114	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000655	0.00114	CcSEcCtD
Hydroxocobalamin—Headache—Topotecan—peripheral nervous system neoplasm	0.000654	0.00113	CcSEcCtD
Hydroxocobalamin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000653	0.00113	CcSEcCtD
Hydroxocobalamin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000653	0.00113	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000653	0.00113	CcSEcCtD
Hydroxocobalamin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000652	0.00113	CcSEcCtD
Hydroxocobalamin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000652	0.00113	CcSEcCtD
Hydroxocobalamin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000652	0.00113	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000649	0.00113	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.00112	CcSEcCtD
Hydroxocobalamin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000648	0.00112	CcSEcCtD
Hydroxocobalamin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000648	0.00112	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.00112	CcSEcCtD
Hydroxocobalamin—Pain—Vincristine—peripheral nervous system neoplasm	0.000646	0.00112	CcSEcCtD
Hydroxocobalamin—Rash—Melphalan—peripheral nervous system neoplasm	0.000644	0.00112	CcSEcCtD
Hydroxocobalamin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000644	0.00112	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000639	0.00111	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000636	0.0011	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000634	0.0011	CcSEcCtD
Hydroxocobalamin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000631	0.00109	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000623	0.00108	CcSEcCtD
Hydroxocobalamin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000623	0.00108	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.00108	CcSEcCtD
Hydroxocobalamin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00062	0.00107	CcSEcCtD
Hydroxocobalamin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000615	0.00107	CcSEcCtD
Hydroxocobalamin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000615	0.00107	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.00107	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000612	0.00106	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—peripheral nervous system neoplasm	0.000608	0.00105	CcSEcCtD
Hydroxocobalamin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000607	0.00105	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00105	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000598	0.00104	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000598	0.00104	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000596	0.00103	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000595	0.00103	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.00102	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000579	0.001	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.001	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000577	0.001	CcSEcCtD
Hydroxocobalamin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000572	0.000991	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000968	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000557	0.000966	CcSEcCtD
Hydroxocobalamin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.000962	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000551	0.000955	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000546	0.000946	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.000931	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000533	0.000925	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000529	0.000917	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000528	0.000916	CcSEcCtD
Hydroxocobalamin—Pain—Etoposide—peripheral nervous system neoplasm	0.000524	0.000908	CcSEcCtD
Hydroxocobalamin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.000899	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000517	0.000897	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000505	0.000875	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000503	0.000871	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0005	0.000867	CcSEcCtD
Hydroxocobalamin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000495	0.000858	CcSEcCtD
Hydroxocobalamin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000494	0.000857	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000492	0.000854	CcSEcCtD
Hydroxocobalamin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000491	0.000852	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000486	0.000843	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000484	0.000839	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000827	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—peripheral nervous system neoplasm	0.000477	0.000826	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000476	0.000826	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000825	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000821	CcSEcCtD
Hydroxocobalamin—Headache—Vincristine—peripheral nervous system neoplasm	0.000474	0.000821	CcSEcCtD
Hydroxocobalamin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.000808	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000457	0.000793	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000783	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000451	0.000782	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000449	0.000778	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000777	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000765	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000764	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000438	0.00076	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.00076	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000757	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000755	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000752	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000433	0.000751	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000748	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000734	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000421	0.000731	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00073	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000729	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000419	0.000726	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000724	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000719	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000703	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000405	0.000702	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.0007	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000699	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000695	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000692	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000397	0.000688	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000679	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000677	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000675	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—COX2—peripheral nervous system neoplasm	0.000387	0.00107	CbGpPWpGaD
Hydroxocobalamin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000386	0.00067	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—ERBB2—peripheral nervous system neoplasm	0.000386	0.00107	CbGpPWpGaD
Hydroxocobalamin—Rash—Etoposide—peripheral nervous system neoplasm	0.000386	0.000669	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—peripheral nervous system neoplasm	0.000386	0.00107	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000386	0.000669	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—TH—peripheral nervous system neoplasm	0.000384	0.00107	CbGpPWpGaD
Hydroxocobalamin—Headache—Etoposide—peripheral nervous system neoplasm	0.000384	0.000665	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	0.000383	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—ERBB2—peripheral nervous system neoplasm	0.000381	0.00106	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ENO2—peripheral nervous system neoplasm	0.00038	0.00105	CbGpPWpGaD
Hydroxocobalamin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000658	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—GNS—peripheral nervous system neoplasm	0.000377	0.00105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ENO2—peripheral nervous system neoplasm	0.000372	0.00103	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GNAS—peripheral nervous system neoplasm	0.000369	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000369	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000367	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000366	0.00101	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SLC2A1—peripheral nervous system neoplasm	0.000365	0.00101	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—BCHE—peripheral nervous system neoplasm	0.000364	0.00101	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000364	0.00101	CbGpPWpGaD
Hydroxocobalamin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000364	0.000631	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000362	0.001	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000626	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—ERBB2—peripheral nervous system neoplasm	0.000361	0.000999	CbGpPWpGaD
Hydroxocobalamin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000621	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.00062	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000617	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	0.000356	0.000985	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000613	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000608	CcSEcCtD
Hydroxocobalamin—MTR—Disease—PPP3R1—peripheral nervous system neoplasm	0.00035	0.000971	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000348	0.000963	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000348	0.000963	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000348	0.000963	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000348	0.000963	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.000345	0.000956	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000595	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000595	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—TH—peripheral nervous system neoplasm	0.000343	0.00095	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—TH—peripheral nervous system neoplasm	0.000343	0.00095	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—AKT1—peripheral nervous system neoplasm	0.000341	0.000945	CbGpPWpGaD
Hydroxocobalamin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000591	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—NRAS—peripheral nervous system neoplasm	0.00034	0.000943	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.00034	0.000942	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000338	0.000936	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GNAS—peripheral nervous system neoplasm	0.000338	0.000936	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000584	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000336	0.000931	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000581	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.000335	0.000928	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000578	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000333	0.000922	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000332	0.000919	CbGpPWpGaD
Hydroxocobalamin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000574	CcSEcCtD
Hydroxocobalamin—MMAB—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000331	0.000918	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000331	0.000918	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.00057	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000568	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—TH—peripheral nervous system neoplasm	0.000327	0.000906	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000323	0.000896	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000323	0.000896	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—BCHE—peripheral nervous system neoplasm	0.000321	0.000889	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.00032	0.000886	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000318	0.000882	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000551	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000551	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000317	0.000877	CbGpPWpGaD
Hydroxocobalamin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000547	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000315	0.000873	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000314	0.00087	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000313	0.000869	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ENO2—peripheral nervous system neoplasm	0.000312	0.000864	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.00054	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000311	0.000861	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000537	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000309	0.000856	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000535	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000308	0.000853	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—AKT1—peripheral nervous system neoplasm	0.000307	0.000851	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTPN11—peripheral nervous system neoplasm	0.000306	0.000849	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000306	0.000848	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000531	CcSEcCtD
Hydroxocobalamin—MTR—Disease—ENO2—peripheral nervous system neoplasm	0.000304	0.000841	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000524	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—TH—peripheral nervous system neoplasm	0.000302	0.000836	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SLC2A1—peripheral nervous system neoplasm	0.0003	0.000832	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.0003	0.000831	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000298	0.000825	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD34—peripheral nervous system neoplasm	0.000297	0.000823	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000296	0.000821	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000296	0.000821	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000296	0.000821	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000514	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000294	0.000814	CbGpPWpGaD
Hydroxocobalamin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000509	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000291	0.000807	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.000291	0.000806	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.00029	0.000803	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000288	0.000798	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000286	0.000792	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000491	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00049	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—PTPN11—peripheral nervous system neoplasm	0.00028	0.000776	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTPN11—peripheral nervous system neoplasm	0.00028	0.000776	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GNAS—peripheral nervous system neoplasm	0.00028	0.000775	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GNAS—peripheral nervous system neoplasm	0.00028	0.000775	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000485	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000274	0.000761	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000274	0.000761	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000274	0.00076	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000475	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000473	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000471	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00047	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000267	0.00074	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000265	0.000735	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000264	0.000732	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PPP3R1—peripheral nervous system neoplasm	0.000264	0.000731	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—BCHE—peripheral nervous system neoplasm	0.000263	0.00073	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000263	0.000728	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000262	0.000726	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000454	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—PTPN11—peripheral nervous system neoplasm	0.00026	0.000722	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.00026	0.000721	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00026	0.00072	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000257	0.000713	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO2—peripheral nervous system neoplasm	0.000254	0.000704	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000253	0.000702	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000438	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—NCAM1—peripheral nervous system neoplasm	0.000252	0.000699	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000437	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TP53—peripheral nervous system neoplasm	0.000252	0.000699	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000251	0.000697	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000435	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000249	0.00069	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—TH—peripheral nervous system neoplasm	0.000248	0.000687	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GNAS—peripheral nervous system neoplasm	0.000246	0.000682	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000245	0.000679	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SLC2A1—peripheral nervous system neoplasm	0.000245	0.000678	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000421	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—ERBB2—peripheral nervous system neoplasm	0.000242	0.000671	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000242	0.00067	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000241	0.000668	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000236	0.000655	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000407	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000406	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000234	0.000648	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000233	0.000645	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTPN11—peripheral nervous system neoplasm	0.000232	0.000643	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTPN11—peripheral nervous system neoplasm	0.000232	0.000643	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000232	0.000642	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.00023	0.000639	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.00023	0.000636	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ENO2—peripheral nervous system neoplasm	0.000229	0.000633	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000227	0.00063	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000394	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00039	CcSEcCtD
Hydroxocobalamin—MUT—Disease—PTPN11—peripheral nervous system neoplasm	0.000221	0.000614	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ERBB2—peripheral nervous system neoplasm	0.000221	0.000614	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ERBB2—peripheral nervous system neoplasm	0.000221	0.000614	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.00022	0.000609	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000217	0.000602	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000377	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000217	0.000601	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000217	0.000601	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000217	0.000601	CbGpPWpGaD
Hydroxocobalamin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000375	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000216	0.000599	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000375	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000373	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000215	0.000596	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—BCHE—peripheral nervous system neoplasm	0.000215	0.000595	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000213	0.000591	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000213	0.00059	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000213	0.00059	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000212	0.000588	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000364	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000207	0.000572	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB2—peripheral nervous system neoplasm	0.000206	0.00057	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000206	0.00057	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000205	0.000568	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000205	0.000567	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTPN11—peripheral nervous system neoplasm	0.000204	0.000566	CbGpPWpGaD
Hydroxocobalamin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000353	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000204	0.000564	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GNAS—peripheral nervous system neoplasm	0.000202	0.00056	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TH—peripheral nervous system neoplasm	0.000202	0.00056	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000202	0.00056	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000201	0.000556	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000201	0.000556	CbGpPWpGaD
Hydroxocobalamin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000347	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.0002	0.000555	CbGpPWpGaD
Hydroxocobalamin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000347	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.0002	0.000553	CbGpPWpGaD
Hydroxocobalamin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000345	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000198	0.00055	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNB1—peripheral nervous system neoplasm	0.000198	0.000549	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000192	0.000532	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000192	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000191	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000191	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000191	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.00019	0.000526	CbGpPWpGaD
Hydroxocobalamin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000327	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000188	0.000521	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000187	0.000519	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000185	0.000512	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SLC2A1—peripheral nervous system neoplasm	0.000184	0.00051	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—peripheral nervous system neoplasm	0.000184	0.00051	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000184	0.00051	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—peripheral nervous system neoplasm	0.000183	0.000508	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—peripheral nervous system neoplasm	0.000183	0.000508	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.00018	0.000499	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000177	0.000491	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—peripheral nervous system neoplasm	0.000175	0.000485	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MYC—peripheral nervous system neoplasm	0.000172	0.000475	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.00017	0.00047	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—peripheral nervous system neoplasm	0.000168	0.000467	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—peripheral nervous system neoplasm	0.000168	0.000467	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTPN11—peripheral nervous system neoplasm	0.000168	0.000465	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GNAS—peripheral nervous system neoplasm	0.000165	0.000457	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000162	0.000448	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—peripheral nervous system neoplasm	0.000162	0.000448	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—peripheral nervous system neoplasm	0.000157	0.000435	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—peripheral nervous system neoplasm	0.000157	0.000435	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—peripheral nervous system neoplasm	0.000157	0.000434	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HGF—peripheral nervous system neoplasm	0.000153	0.000424	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000151	0.000419	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000148	0.000409	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—peripheral nervous system neoplasm	0.000146	0.000404	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000145	0.000403	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—peripheral nervous system neoplasm	0.00014	0.000387	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—peripheral nervous system neoplasm	0.00014	0.000387	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000139	0.000385	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTPN11—peripheral nervous system neoplasm	0.000137	0.000379	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—peripheral nervous system neoplasm	0.000135	0.000373	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—peripheral nervous system neoplasm	0.000133	0.000369	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—peripheral nervous system neoplasm	0.000133	0.000368	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.00013	0.000361	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—peripheral nervous system neoplasm	0.00013	0.00036	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—peripheral nervous system neoplasm	0.00013	0.00036	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—peripheral nervous system neoplasm	0.000124	0.000344	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—peripheral nervous system neoplasm	0.000123	0.000341	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—peripheral nervous system neoplasm	0.000123	0.000341	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—peripheral nervous system neoplasm	0.000123	0.000341	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—peripheral nervous system neoplasm	0.000119	0.00033	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000119	0.000329	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000115	0.000319	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—peripheral nervous system neoplasm	0.000115	0.000317	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—peripheral nervous system neoplasm	0.000114	0.000317	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000113	0.000313	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTPN11—peripheral nervous system neoplasm	0.000112	0.000309	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000111	0.000306	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—peripheral nervous system neoplasm	0.000109	0.000302	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—peripheral nervous system neoplasm	0.000109	0.000302	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—peripheral nervous system neoplasm	0.000108	0.0003	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000104	0.000288	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTPN11—peripheral nervous system neoplasm	0.000103	0.000285	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—peripheral nervous system neoplasm	0.000102	0.000283	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—peripheral nervous system neoplasm	0.000102	0.000283	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—peripheral nervous system neoplasm	0.000101	0.00028	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—peripheral nervous system neoplasm	0.000101	0.00028	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—peripheral nervous system neoplasm	9.96e-05	0.000276	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—peripheral nervous system neoplasm	9.74e-05	0.00027	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—peripheral nervous system neoplasm	9.4e-05	0.00026	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—peripheral nervous system neoplasm	9.11e-05	0.000253	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—peripheral nervous system neoplasm	9.11e-05	0.000253	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—peripheral nervous system neoplasm	9.02e-05	0.00025	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—peripheral nervous system neoplasm	9.02e-05	0.00025	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—peripheral nervous system neoplasm	8.99e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—peripheral nervous system neoplasm	8.82e-05	0.000244	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—peripheral nervous system neoplasm	8.6e-05	0.000238	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—peripheral nervous system neoplasm	8.47e-05	0.000235	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.42e-05	0.000233	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—peripheral nervous system neoplasm	8.23e-05	0.000228	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—peripheral nervous system neoplasm	8.14e-05	0.000226	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.09e-05	0.000224	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—peripheral nervous system neoplasm	7.94e-05	0.00022	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—peripheral nervous system neoplasm	7.66e-05	0.000212	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—peripheral nervous system neoplasm	7.55e-05	0.000209	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—peripheral nervous system neoplasm	7.55e-05	0.000209	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.44e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—peripheral nervous system neoplasm	7.38e-05	0.000205	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.21e-05	0.0002	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—peripheral nervous system neoplasm	7.2e-05	0.0002	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.14e-05	0.000198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—peripheral nervous system neoplasm	6.71e-05	0.000186	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—peripheral nervous system neoplasm	6.65e-05	0.000184	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—peripheral nervous system neoplasm	6.52e-05	0.000181	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—peripheral nervous system neoplasm	6.19e-05	0.000172	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—peripheral nervous system neoplasm	6.02e-05	0.000167	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—peripheral nervous system neoplasm	5.77e-05	0.00016	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.7e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—peripheral nervous system neoplasm	5.46e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—peripheral nervous system neoplasm	5.31e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.17e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—peripheral nervous system neoplasm	4.91e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—peripheral nervous system neoplasm	4.53e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—peripheral nervous system neoplasm	4.45e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.34e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—peripheral nervous system neoplasm	4.33e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.04e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—peripheral nervous system neoplasm	4e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.32e-05	9.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.17e-05	8.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.8e-05	7.76e-05	CbGpPWpGaD
